Literature DB >> 15619626

Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer.

Daniela M Dinulescu1, Tan A Ince, Bradley J Quade, Sarah A Shafer, Denise Crowley, Tyler Jacks.   

Abstract

Epithelial ovarian tumors present a complex clinical, diagnostic and therapeutic challenge because of the difficulty of early detection, lack of known precursor lesions and high mortality rates. Endometrioid ovarian carcinomas are frequently associated with endometriosis, but the mechanism for this association remains unknown. Here we present the first genetic models of peritoneal endometriosis and endometrioid ovarian adenocarcinoma in mice, both based on the activation of an oncogenic K-ras allele. In addition, we find that expression of oncogenic K-ras or conditional Pten deletion within the ovarian surface epithelium gives rise to preneoplastic ovarian lesions with an endometrioid glandular morphology. Furthermore, the combination of the two mutations in the ovary leads to the induction of invasive and widely metastatic endometrioid ovarian adenocarcinomas with complete penetrance and a disease latency of only 7 weeks. The ovarian cancer model described in this study recapitulates the specific tumor histomorphology and metastatic potential of the human disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15619626     DOI: 10.1038/nm1173

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  217 in total

1.  Evaluation of KRAS Gene Expression and LCS6 Variant in Genomic and Cell-Free DNA of Iranian Women With Endometriosis.

Authors:  Maryam Shahrabi Farahani; Shirin Shahbazi; Soheila Amini Moghaddam; Reza Mahdian
Journal:  Reprod Sci       Date:  2014-10-30       Impact factor: 3.060

2.  Measuring the intra-individual variability of the plasma proteome in the chicken model of spontaneous ovarian adenocarcinoma.

Authors:  Adam M Hawkridge; Rebecca B Wysocky; James N Petitte; Kenneth E Anderson; Paul E Mozdziak; Oscar J Fletcher; Jonathan M Horowitz; David C Muddiman
Journal:  Anal Bioanal Chem       Date:  2010-07-17       Impact factor: 4.142

3.  MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma.

Authors:  Y Zhai; A Iura; S Yeasmin; A B Wiese; R Wu; Y Feng; E R Fearon; K R Cho
Journal:  Oncogene       Date:  2011-04-18       Impact factor: 9.867

4.  A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy.

Authors:  Christian M Becker; Renee D Wright; Ronit Satchi-Fainaro; Tae Funakoshi; Judah Folkman; Andrew L Kung; Robert J D'Amato
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

5.  Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis.

Authors:  Lan Mo; Xiaoyong Zheng; Hong-Ying Huang; Ellen Shapiro; Herbert Lepor; Carlos Cordon-Cardo; Tung-Tien Sun; Xue-Ru Wu
Journal:  J Clin Invest       Date:  2007-01-25       Impact factor: 14.808

Review 6.  Recombinant adenovirus as a methodology for exploration of physiologic functions of growth factor pathways.

Authors:  Kevin Wei; Frank Kuhnert; Calvin J Kuo
Journal:  J Mol Med (Berl)       Date:  2007-09-22       Impact factor: 4.599

7.  Molecular imaging reveals a role for AKT in resistance to cisplatin for ovarian endometrioid adenocarcinoma.

Authors:  Hanxiao Wang; Stefanie Galbán; Rong Wu; Brittany M Bowman; Amanda Witte; Katrin Vetter; Craig J Galbán; Brian D Ross; Kathleen R Cho; Alnawaz Rehemtulla
Journal:  Clin Cancer Res       Date:  2012-10-24       Impact factor: 12.531

8.  Endometriosis and ovarian cancer.

Authors:  Milena Králíčková; Vaclav Vetvicka
Journal:  World J Clin Oncol       Date:  2014-12-10

9.  Induction of papillary carcinoma in human ovarian surface epithelial cells using combined genetic elements and peritoneal microenvironment.

Authors:  Jingfang Zheng; Imelda Mercado-Uribe; Daniel G Rosen; Bin Chang; Peishu Liu; Gong Yang; Anais Malpica; Honami Naora; Nelly Auersperg; Gordon B Mills; Robert C Bast; Jinsong Liu
Journal:  Cell Cycle       Date:  2010-01-05       Impact factor: 4.534

10.  Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment.

Authors:  Kenneth E Hung; Marco A Maricevich; Larissa Georgeon Richard; Wei Y Chen; Michael P Richardson; Alexandra Kunin; Roderick T Bronson; Umar Mahmood; Raju Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.